Log in to save to my catalogue

Aberrant MicroRNAs in Pancreatic Cancer : Researches and Clinical Implications

Aberrant MicroRNAs in Pancreatic Cancer : Researches and Clinical Implications

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_818f8205b1ad4958a10473c21272189e

Aberrant MicroRNAs in Pancreatic Cancer : Researches and Clinical Implications

About this item

Full title

Aberrant MicroRNAs in Pancreatic Cancer : Researches and Clinical Implications

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

Journal title

Gastroenterology research and practice, 2014-01, Vol.2014 (2014), p.1-11

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

More information

Scope and Contents

Contents

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a high rate of mortality and poor prognosis. Numerous studies have proved that microRNA (miRNA) may play a vital role in a wide range of malignancies, including PDAC, and dysregulated miRNAs, including circulating miRNAs, are associated with PDAC proliferation, invasion, chemo...

Alternative Titles

Full title

Aberrant MicroRNAs in Pancreatic Cancer : Researches and Clinical Implications

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_818f8205b1ad4958a10473c21272189e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_818f8205b1ad4958a10473c21272189e

Other Identifiers

ISSN

1687-6121

E-ISSN

1687-630X

DOI

10.1155/2014/386561

How to access this item